Harmony Biosciences
M$714.50
106
+M$13.50+1.93%Thursday 14:05
Statistics
Day High
714.5
Day Low
714.5
52W High
714.5
52W Low
701
Volume
0
Avg. Volume
125
Mkt Cap
41.61B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 4Expected
Q2 2026
Next
16.49
18.35
20.21
22.07
Expected EPS
20.448001377260002
Actual EPS
N/A
Financials
18.48%Profit Margin
Profitable16.32BRevenue
3.01BNet Income
Analyst Ratings
$648.28Average Price Target
The highest estimate is 816.01.
From 6 ratings within the last 6 months. This is not an investment recommendation.
From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow HRMY.MX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Jazz Pharmaceuticals
JAZZ
Mkt Cap14.02B
Axsome Therapeutics
AXSM
Mkt Cap7.57B
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.09B
Biogen
BIIB
Mkt Cap37.49B
Supernus Pharmaceuticals
SUPN
Mkt Cap2.47B
Palatin Technologies
PTN
Mkt Cap8.9M
About
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Show More
CEO
Jeffrey Dayno
Employees
293
Country
United States
ISIN
US4131971040
Listings
0 Comments
Share your thoughts
FAQs
What is Harmony Biosciences stock price today?▼
The current price of HRMY.MX is M$714.50 MXN — it has increased by +1.93% in the past 24 hours. Watch Harmony Biosciences stock price performance more closely on the chart.
What is Harmony Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Mexican Exchange exchange Harmony Biosciences stocks are traded under the ticker HRMY.MX.
What is Harmony Biosciences market cap?▼
Today Harmony Biosciences has the market capitalization of 41.61B
When is the next Harmony Biosciences earnings date?▼
Harmony Biosciences is going to release the next earnings report on November 4, 2026.
What were Harmony Biosciences earnings last quarter?▼
HRMY.MX earnings for the last quarter are 22.07 MXN per share, whereas the estimation was 16.49 MXN resulting in a +33.84% surprise. The estimated earnings for the next quarter are N/A MXN per share.
What is Harmony Biosciences revenue for the last year?▼
Harmony Biosciences revenue for the last year amounts to 16.32B MXN.
What is Harmony Biosciences net income for the last year?▼
HRMY.MX net income for the last year is 3.01B MXN.
How many employees does Harmony Biosciences have?▼
As of November 2, 2026, the company has 293 employees.
In which sector is Harmony Biosciences located?▼
Harmony Biosciences operates in the Health & Wellness sector.
When did Harmony Biosciences complete a stock split?▼
Harmony Biosciences has not had any recent stock splits.
Where is Harmony Biosciences headquartered?▼
Harmony Biosciences is headquartered in PLYMOUTH MEETING, United States.